|
Volumn 117, Issue 3, 2002, Pages 755-758
|
Interferon and ribavirin as frontline treatment for chronic hepatitis C infection in thalassaemia major
|
Author keywords
Hepatitis C; Thalassaemia; Treatment
|
Indexed keywords
ANTIVIRUS AGENT;
RECOMBINANT ALPHA2B INTERFERON;
RIBAVIRIN;
ADOLESCENT;
ADULT;
ARTICLE;
CLINICAL ARTICLE;
CONTROLLED STUDY;
DOSE RESPONSE;
FEMALE;
GENOTYPE;
HEMOLYSIS;
HEPATITIS C;
HUMAN;
MALE;
PRIORITY JOURNAL;
SCHOOL CHILD;
THALASSEMIA MAJOR;
ADOLESCENT;
ADULT;
ANTIVIRAL AGENTS;
BETA-THALASSEMIA;
BLOOD TRANSFUSION;
CHILD;
DRUG THERAPY, COMBINATION;
FEMALE;
FOLLOW-UP STUDIES;
GENOTYPE;
HEPACIVIRUS;
HEPATITIS C, CHRONIC;
HUMANS;
INTERFERON ALFA-2B;
MALE;
RIBAVIRIN;
|
EID: 0036106786
PISSN: 00071048
EISSN: None
Source Type: Journal
DOI: 10.1046/j.1365-2141.2002.03491.x Document Type: Article |
Times cited : (55)
|
References (11)
|